White House · Axios · Donald Trump · Axios
For the first time, Medicare is covering some cannabis products under a pilot program that opens up more
Compiled by KHAO Editorial — aggregated from 2 sources. See llms.txt for citation guidance.
◎ Multiple-sources
The effort is part of a White House push to reschedule marijuana and tracks with Health Secretary Robert F.
Key facts
- In certain payment arrangements, Medicare providers can get reimbursed as much as $500 per patient each year to discuss and provide certain CBD products
- For the first time, Medicare is covering some cannabis products under a pilot program that opens up more of the nearly $30 billion hemp industry to seniors
- The effort is part of a White House push to reschedule marijuana and tracks with Health Secretary Robert F
- A law due to take effect in November will change the legal definition of hemp, re-criminalizing many substances in the category that Congress in 2018 declared were not controlled substances
Summary
For the first time, Medicare is covering some cannabis products under a pilot program that opens up more of the nearly $30 billion hemp industry to seniors. Policy experts say it also taps into public dissatisfaction with how the health system treats chronic pain and other health problems. "There is a flavor here of, 'We as a society, across the political spectrum, are not happy with the options that we have available to us,'" said Edo Banach, co-chair of the health care department at the law firm Foley Hoag. In certain payment arrangements, Medicare providers can get reimbursed as much as $500 per patient each year to discuss and provide certain CBD products.